AURX insider trading
OTC Markets OTCQB HealthcareNuo Therapeutics, Inc.: insider trade history from SEC Form 4 filings.
About Nuo Therapeutics, Inc.
Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.
Company website: www.nuot.com
AURX insider activity at a glance
FilingIQ tracks 63 insider transactions for AURX in filings since Aug 14, 2017. The most recent transaction is dated Aug 28, 2026.
Across the full history, 13 open-market purchases
and 10 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on AURX insider trades is 62.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest AURX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading AURX
Frequently asked
- How many insider trades does FilingIQ track for AURX?
- FilingIQ tracks 63 Form 4 insider transactions for AURX (Nuo Therapeutics, Inc.), covering filings from Aug 14, 2017 onwards. 4 of those are dated within the last 90 days.
- Are AURX insiders net buyers or net sellers?
- Across the full Form 4 history for AURX, 13 transactions (21%) were open-market purchases and 10 (16%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does AURX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is AURX in?
- Nuo Therapeutics, Inc. (AURX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $77.25M.
Methodology & sources
Every AURX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.